Nitto Denko Avecia Inc. has opened its new oligonucleotide API manufacturing facility in Milford, MA. The expansion adds 20,000 sq.-ft. of manufacturing and office space at the and provides CGMP oligonucleotide manufacturing capacity up to 1.8mol. The total capacity of Avecia’s Milford site has now more than doubled up to 3.0mol, which makes Avecia in Milford, MA the largest oligonucleotide manufacturing site in the world. According to Avecia’s president Detlef Rethage, “This expansion will h...